STUDY QUESTION: Do obese levels of advanced glycation end products (AGEs) within the uterine cavity detrimentally alter tissue function in embryo implantation and placental development?
PARTICIPANTS/MATERIALS, SETTING, METHODS: Levels of AGEs examined within uterine lavage assessed by ELISA to determine differences between lean and obese women. Expression and localization of AGEs, receptor for AGEs (RAGE) and NFκB within endometrial tissues obtained from lean and obese women determined by immunohistochemistry. Endometrial epithelial cells (ECC-1), primary human stromal cells and trophoblast cells (HTR8-SVneo) treated with lean (2000 nmol/mol lysine) or obese (8000 nmol/mol lysine) uterine levels of AGEs and p65 NFκB (western immunoblot), real-time adhesion, proliferation migration and invasion (xCelligence real-time cell function analysis), decidualization (cell morphology and prolactin release), ER stress (western immunoblot for p-PERK) determined. Co-cultures of endometrial epithelial cells and blastocyst mimics (trophectoderm spheroids) similarly treated with lean or obese uterine levels of AGEs to determine their impact on embryo implantation.
MAIN RESULTS AND THE ROLE OF CHANCE: AGEs were significantly elevated (P = 0.004) within the obese (6503.59 μmol/mol lysine) versus lean (2165.88 μmol/mol lysine) uterine cavity (uterine lavage) with increased immunostaining for AGEs, RAGE and NFkB within obese endometrial tissues during the proliferative phase of the menstrual cycle. Obese uterine levels of AGEs inhibited adhesion and proliferation of endometrial epithelial (ECC-1) cells compared to treatment with lean uterine levels of AGEs. Obese uterine AGE levels impacted
Introduction
Infertility is a growing problem worldwide, estimated to affect around one in six couples in western countries. There are many potential 'causes' of infertility including issues with gamete quality, endocrinological disease and tubal blockages. One known underlying cause of infertility associated with modern lifestyles, and growing exponentially, is obesity.
Obesity is classified as a BMI of >30 kg/m 2 and is now considered to be an epidemic. Worldwide obesity has doubled since 1980, with 13% of the global population now obese, including around 36% of adults in North America. If US trends continue unabated, it is estimated that~50% of all adults will be obese by 2030 (World Health Organization, 2016) . While traditionally associated with high income westernized countries, obesity is also a growing problem in low and middle-income countries, particularly in urban settings. Obesity is a known risk factor for ovulation defects and is strongly linked with anovulation (Giviziez et al., 2016) . However, even in the absence of ovulatory dysfunction, obese women are at an increased risk of sub-fertility. In a study of 3029 sub-fertile couples, for every increase in BMI unit above 29, the chance of spontaneous conception in ovulatory women decreased by 5% (van der Steeg et al., 2008) being 26% lower than the reference group (BMI 21-29) for BMI of 35 and to 43% lower than the reference group for BMI > 40.
Growing evidence strongly implicates obesity in mediating endometrial dysfunction. A specific role for endometrial alterations in obesity-related infertility was identified by oocyte donation and surrogate third party reproduction studies. A study of 9587 first cycles of ovum donation from normal weight donors revealed a negative impact of recipient obesity (BMI > 35) on implantation rate, clinical pregnancy and live birth rate (Bellver et al., 2013) , with these observations confirmed in a larger cohort (Provost et al., 2016) . Furthermore, surrogate obesity negatively impacted pregnancy rates in third-party reproduction (DeUgarte et al., 2010) and frozen embryo transfer studies (Dessolle et al., 2009) . Dietinduced obesity impairs endometrial stromal cell decidualization, a critical adaptation required for pregnancy (Rhee et al., 2016) . The incidence of pre-eclampsia, a disease associated with deficient trophoblast invasion and spiral artery remodeling, is also increased in obese women, with a greater prevalence as the class of obesity increases (Spradley et al., 2015) . Obese women and high-fat diet fed obese animal models exhibit significant placental insufficiency, placental lesions and reduced spiral artery remodeling which appear to be associated with reduced trophoblast invasion (Higgins et al., 2013; Hayes et al., 2014; Huang et al., 2014) . Collectively, these data strongly implicate a negative impact of obesity on human endometrial and trophoblast function. However, the specific mediators of inflammation and cellular dysfunction in the context of obesity are currently unknown.
Maternal-fetal communication requires intricate dialogue between the pre-implantation blastocyst and maternal endometrium to achieve appropriate implantation, placentation and pregnancy. While many factors within the uterine cavity facilitate this communication (Binder et al., 2014 (Binder et al., , 2016 , the above studies suggest that specific factors within the cavity that detrimentally influence this dialogue in obese women. This study aimed to identify and characterize the impact of obesity-related factors within the uterine cavity that detrimentally impact endometrial function, implantation competence and placental development. We examined a family of post-translational protein modifications, the advanced glycation end products (AGEs), which are elevated systemically in obesity and are derivatives of fat and sugar related molecules.
Materials and Methods

Ethical approval
Ethical approval for human tissue collection was obtained from Institutional Ethics Committees at Monash Health (Human Research Ethics Committee B) and Monash Surgical Private Hospital. Written informed consent was obtained from each patient prior to tissue collection after explicit explanation of the project by a research nurse.
Tissue and uterine lavage collection
Human uterine lavage and endometrial tissue were collected from fertile normally cycling women (≥1 previous parous pregnancy) or infertile women (inability to conceive after 12 months of unprotected sex) with no known endometrial pathology (i.e. endometriosis, fibroids, polyps). Height and weight data were obtained from patient's clinical records and BMI calculated.
Uterine lavage
A soft infant feeding tube was inserted through the external os and cervix to 164 the level of the internal os. 3 ml of sterile saline was gently infused into the uterine cavity and 165 then slowly drawn back. 5 ul of protease inhibitors (Merck Millipore, Bayswater, VIC, 166 Australia) was added, sample centrifuged at 1000rpm for 5 minutes to remove cellular debris, supernatant was aliquoted and stored at −80°C.
Endometrial tissue
Tissue was collected by curettage across the menstrual cycle. Due to the mode of altruistic tissue collection, no urine or serum collection was possible to more accurately determine tissue dating. Menstrual cycle stage was determined by standard histological dating by a highly experienced gynecological pathologist; dating via histological analysis may be subject to limitations (Diaz-Gimeno et al., 2013; Murray et al., 2004) . Endometrial biopsies were formalin-fixed overnight (16 ± 1 h) at 4°C, and processed to wax under standard conditions.
Primary stromal cell isolation
Endometrial tissues collected as described above and isolated following standard protocols . Cell purity within each stromal cell preparation was estimated to be >95% with no evidence of endometrial epithelial cells in any stromal preparation used. Overview of cellular experiments provided in Supplementary Fig. S1 .
Cell culture
All cell lines were proven to be free of mycoplasma prior to use and, where information had been deposited, their identity was independently validated via short tandem repeat (STR) DNA profiling of human cell lines per ATCC guidelines (Greening et al., 2016) .
ECC-1 are an endometrial cancer cell line with characteristics of the endometrial luminal epithelial layer. They were routinely maintained in a 1:1 mix of DMEM:F12 Glutamax (Gibco, Invitrogen, Scoresby, Victoria, Australia) supplemented with 1% v/v penicillin/streptomycin (p/s) and 10% v/v fetal calf serum (FCS, Gibco, Invitrogen) .
Trophectodermal cells (kind gift of Prof Susan Fisher) are derived from trophoblast stem cells (Zdravkovic et al., 2015) . They were routinely maintained in a 1:1 mix of DMEM:F12 Glutamax (Gibco, Invitrogen) supplemented with 1% v/v p/s and 10% v/v FCS with addition of 10ng/ml basic fibroblast growth factor (bFGF) and 10 nM SB431542 (Tocris Bioscience, In Vitro Technologies, Noble Park, Victoria, Australia). Cells were grown in T25 flasks coated with 0.5% gelatin prior to experimental seeding.
HTR8/SV-neo cells are an invasive, human extravillous trophoblast cell line derived from first trimester villous explants (kind gift of Professor Charles Graham, Queen's University, Kingston, Canada). HTR8/SV-neo cells were routinely cultured and maintained in T75 flasks in a 1:1 mix of DMEM:F12 Glutamax (Gibco, Invitrogen) supplemented with 1% v/v p/s and 10% v/v FCS (as above).
Manufacture of AGEs-human serum albumin
A 10 mg/ml human serum albumin (HSA) (Fraction V HSA, Sigma Aldrich, Castle Hill, New South Wales, Australia) was combined with 0.2 M phosphate buffered saline (PBS). A 90 g/l D-glucose was added to a final glucose concentration of 0.5 M to produce AGEs. All solutions were sterile filtered using 0.2 μm Micropore filters in a sterile laminar flow hood and subsequently incubated in the dark for three months at 37°C (Booth et al., 1997) . HSA/glucose (AGE-HSA) produced a yellow-brown liquid characteristic of the Maillard reaction. After 3 months incubation, samples were dialyzed (SnakeSkin TM Dialysis Tubing, ThermoScientific, Scoresby, Victoria, Australia), in 0.2 M PBS at 4°C. Dialyzed preparations were sterile filtered (as above) prior to endotoxin removal (Adam et al., 1995) .
AGE ELISA
An in-house indirect AGE ELISA was used to assess AGE concentrations within manufactured AGE-HSA preparations (above) and human uterine lavage samples (Degenhardt et al., 2002; Forbes et al., 2001) . Sample (diluted 1:250) or standard were diluted in 50 mm carbonate buffer (pH 9.6), added to a microtiter plate (Nunc-Immuno MaxiSorp, Sigma Aldrich, Castle Hill, New South Wales, Australia) and incubated overnight. After washing, wells were blocked for 1 h in 1% BSA (Sigma), washed and rabbit polyclonal anti-CML antibody (5 μg/ml) (Forbes et al., 2001) added to each well. After 2 h wells were washed and 0.2 μg/ml goat-anti rabbit IgG biotinylated antibody (Dako Corp., Carpinteria, CA) added to each well. Finally, streptavidin horseradish peroxidase (Dako Corp.), diluted 1/5000, was added. Wells were developed with 3,3′, 5, 5′-tetramethyl benzidine substrate (Sigma), and reaction was terminated 1.8 M H 2 SO 4 . The absorbance was quantitated at 450 nm. The limit of detection of the assay was 8.0 nmol/mol lysine. The interassay coefficient of variation was 7.3%. The intraassay coefficient of variation was 5.5%. The linearity of dilution of the assay was r 2 = 0.91. Results are expressed in nanomoles per mole lysine as determined in the standard by selected ion monitoring gas chromatography-mass spectrometry (Degenhardt et al., 2002) . Uterine lavage from lean (n = 11 proliferative phase, n = 6 secretory phase) and obese (n = 9 proliferative phase, n = 6 secretory phase) women were examined.
AGE concentrations in the prepared AGE-HSA solution were 65 000 μmol/mol lysine. AGE-HSA concentrations used in in vitro experimental paradigms (below) selected to mimic the approximate AGE concentrations within the lean (2000 nmol/mol lysine) or obese (8000 nmol/mol lysine) uterine cavity.
Multiplex assay
Uterine lavage was assayed using a 25-plex chemokine/cytokine assay (Invitrogen) per manufacturer's recommendations to examine IL-1β, IL-10, IFN-α, IL-6, IL-12, RANTES, Eotaxin, IL-13, IL-15, IL-17, MIP-1α, MIP-1β, GM-CSF, MCP-1, IL-5, IFN-γ, TNF-α, IL-RA, IL-2, IL-7, IP-10, IL-2R, MIG, IL-4, IL-8 . Uterine lavage from lean (n = 4) and obese (n = 14) women were examined.
Immunohistochemistry
Immunohistochemistry performed as previously described (Whitby et al., 2017) with overnight at 4°C with rabbit anti-AGE at 1:5000, goat anti-RAGE at 1:2000, mouse anti-CML at 1:10 000 (all Abcam) or an isotype matched IgG negative control. Tissues from ≥5 lean or obese women were examined. Stained tissues were digitally quantified in a blinded unbiased manner using ImageJ Fiji (https://fiji.sc/).
Western immunoblot
ECC-1 cells were treated ('primed') with estradiol-17β (10 −8 M; estrogen)
in the presence of 'lean' (2000 μmol/mol lysine) or 'obese' (8000 μmol/ mol lysine) AGE-HSA for 24 h. The following day, these treatments were continued or replaced with estrogen (10 −8 M)/medroxyprogesterone acetate (10 −7 M; progesterone) in the presence of 'lean' (2000 μmol/mol lysine) or 'obese' (8000 μmol/mol lysine) AGE-HSA for a further 24 h.
Cells were lysed and western immunoblot for cytoplasmic IκB or nuclear NFκB performed as described . three separate experimental replicates were performed. Primary human endometrial stromal cells were seeded at 1 × 10 6 cells per well in six well plates in 10% charcoal-stripped (cs) FCS/DMEM-F12. Cells were then treated with 2% csFCS/DMEM-F12 media containing 'decidualizing treatment' (10 −8 M estrogen/10 −7 M progesterone) to induce decidualization in the presence of 'lean' (2000 μmol/mol lysine) or 'obese' (8000 μmol/mol lysine) AGE-HSA. The media were changed every 2 days to replenish hormones and AGEs for 12 days followed by collection of conditioned media for prolactin assay (below), cells were lysed in radioimmunoprecipitation assay (RIPA) buffer with protease inhibitors and lysates prepared (Whitby et al., 2017) . Western immunoblotting was performed using 25 ul of lysate from each treatment condition (n = 6 stromal cell preparations). Membranes incubated overnight at 4°C with phospho-PERK (ER stress marker, 1:500, Santa Cruz, Bio-Strategy Laboratory Products, Tingalpa, Queensland, Australia) followed by incubation with goat anti-rabbit peroxidase antibody and development. Immunoblots were then stripped and probed with peroxidase labeled β-actin (1:10 000, Cell Signaling, Genesearch PTY, Arundel, Queensland, Australia) to control for loading and proteins visualized as above. Protein intensity was determined by densitometry (Image Labs, BioRad, Gladesville, New South Wales, Australia), and normalized against β-actin.
Prolactin assay
Primary human endometrial stromal cells were treated as above and conditioned media collected after 12 days of treatment. Prolactin (PRL) assays were performed at Monash Health Pathology as previously described .
Spheroid adhesion assay
Trophectodermal cells were seeded in trophectodermal cell media (DMEM/F12 Glutamax, 10% FCS, 1% p/s, 10 ng/ml bFGF, 10 nM SB431542) at 2.5 × 10 3 cells per well into round bottom 96 well plates in the presence of 20% methylcellulose for 48 h to facilitate spheroid formation. These spheroids are a similar size to a human blastocyst and are used as a mimic of human embryos. In total, 20 spheroids were placed into 15 ml centrifuge tubes and washed three times. Concurrent with spheroid manufacture, ECC-1 cells were treated with AGEs/hormones as indicated above. After 24 h of estrogen/progesterone/AGE-HSA treatment of endometrial epithelial cells, spheroids were re-suspended in DMEM/F12 media containing 1% FCS and the above treatments and placed onto pretreated ECC-1 cells for 6 h. Spheroids were then counted to determine the total number of spheroids per well. Media were removed and the epithelial cell/spheroid co-cultures gently washed with PBS to remove nonadhered spheroids. The number of firmly adhered spheroids was counted and adhered spheroids expressed as a % of total spheroids. The five separate experimental replicates were performed.
Real-time cell function
Examination of cell function in real time was examined using the label-free xCelligence system as previously described (Evans et al., 2015) .
Adhesion/proliferation
ECC-1 cells were seeded at 5 × 10 5 cells per well in six well plates, allowed to settle overnight and then treated with AGEs/hormones as indicated above. Treated cells were trypsinised and 2 × 10 4 cells per well transferred to fibronectin coated xCelligence adhesion/proliferation plates (E-Plates, ACEA Biosciences) with the same treatments continued. Readings were taken; (i) every 15 s for 5 h to determine effect of treatment on adhesion and (ii) every 15 min for 48 h to determine effect of treatment on proliferation. All treatments were seeded in quadruplicate wells on each plate. Five separate experimental replicates were performed.
Migration/invasion
HTR8/SV-neo cells were seeded at 5 × 10 5 cells per well in six well plates, allowed to settle overnight and then deprived of serum for 8 h then treated with 'lean' (2000 μmol/mol lysine) or 'obese' (8000 μmol/mol lysine) AGE-HSA for 24 h. To investigate cell invasion, the upper chamber of a cell invasion/migration (CIM) plate was coated with 25 μl of a 1:10 dilution of growth factor reduced, phenol red free matrigel for 30 min prior to addition of 50 μl of serum free medium and background reading; migration assays were performed without matrigel coating. A 10% FCS media was used as a chemoattractant. The 4 × 10 4 pre-treated cells were then seeded in serum free medium into the upper chamber and treatments continued. Readings were taken every 15 min for up to 48 h to determine effect of treatment on migration or invasion. Each treatment was performed in quadruplicate wells. Five separate experimental replicates were performed.
Statistics
GraphPad Prism Version 6 for Windows (La Jolla, CA, USA) was used for all statistical analyses. Before analysis, all data was tested for normality. If the data was found to be non-parametric, a Kruskal-Wallis or Mann-Whitney U analysis was performed. If the data was parametric, one-way ANOVA with a Tukey's or Dunnett's post-hoc test or an unpaired t-test was performed.
Significance was given as P < 0.05, and all data was presented as the mean plus/minus the standard error of the mean (mean ± SEM).
Results
The obese uterine microenvironment is characterized by AGE accumulation ELISA analysis of uterine lavage (Fig. 1A) collected from obese women (BMI > 30, n = 9) demonstrated an accumulation of AGEs within the uterine cavity versus lean women (BMI > 19 < 25, n = 11) during the proliferative phase of the menstrual cycle (P = 0.004). AGE accumulation demonstrated a non-significant increase within the uterine cavity in both obese (n = 7) and lean n = 6) women during the secretory phase of the cycle, with a non-significant increase in AGEs maintained within the obese versus lean women (P = 0.06). Immunohistochemical analysis of proliferative endometrial tissue showed an accumulation of AGEs within the endometrium of obese women (Fig. 1C , n = 6) compared with lean women (Fig. 1B , n = 6). AGEs mainly accumulated within the endometrial stroma of obese women; however, staining was also apparent within the glandular epithelial cells. Limited AGE staining was observed within the lean endometrium. Quantification demonstrated a significant increase in AGEs within the obese endometrium ( Fig. 1D , P = 0.017). The specific AGE species carboxymethyl lysine (CML) was present within stromal and epithelial compartments of both lean (Fig. 1E , n = 6) and obese (Fig. 1F , n = 6) endometrium. However, quantification of immunostaining demonstrated a significant increase in CML within the obese endometrium ( Fig. 1G , P = 0.022). AGEs mediate down-stream signaling via the receptor for AGEs (RAGE). Strong RAGE immunostaining was observed within the obese endometrium (Fig. 1I , n = 6) localized mainly to the glandular epithelium, with some staining within the stromal compartment; faint RAGE immunoreactivity was observed within the lean endometrium (Fig. 1H, n = 6 ). Quantification demonstrated a significant increase in , red, n = 9) versus uterine lavage obtained from lean subjects (BMI 19.5-25 kg/m 2 , blue, n = 11), during the proliferative phase (P = 0.004, Fig. 1A ) but during the secretory phase is not significant, (P = 0.06, BMI > 30 kg/m 2 , red, obese, n = 7; BMI 19.5-25 kg/m 2 , blue, lean n = 6, Fig. 1A ). AGEs demonstrate significant immunostaining within the endometrial stroma of proliferative phase endometrial tissues obtained from obese women (Fig. 1C ) versus tissues obtained from lean women (Fig. 1B , quantification Fig. 1D , P = 0.017) with significantly more intense immunostaining for carboxymethyl lysine noted within the obese (Fig. 1F) versus lean (Fig. 1E ) endometrium (quantification, Fig. 1G , P = 0.022). Receptor for advanced glycation end products (RAGE) is significantly more intensely immunostained within the obese endometrial glandular epithelium (Fig. 1I) , with only faint immunostaining observed in the lean endometrium (Fig. 1H , quantification Fig. 1J , P = 0.018). Data presented as mean ± SEM. Scale bars in Fig. 1B , C, H and I = 20 μM, Fig. 1E and F = 50 μM. Isotype matched IgG negative control sections of same tissues inset into each panel.
RAGE within the obese endometrium ( Fig. 1J , P = 0.018). No staining was noted in isotype matched negative control sections (inset in each panel).
Inflammatory factors are elevated within the uterine cavity of obese patients
AGEs, acting via their receptor RAGE, activate down-stream proinflammatory signaling including chemokine and cytokine production.
Multiplex analysis of uterine lavage demonstrated a non-significant elevation in interferon alpha (IFN-α) ( Fig. 2A , P = 0.05) and IL-6 ( Fig. 2B , P = 0.06) with significant elevation in MCP-1 (Fig. 2C , P = 0.016), CXCL10 ( Fig. 2D , P = 0.016), CXCL8 ( Fig. 2E , P = 0.048) and IL-15 ( Fig. 2F , P = 0.012) within the obese (n = 14) versus lean (n = 4) uterine cavity. These data confirm the co-existence of an inflammatory milieu within the obese uterine environment associated with elevated AGEs.
NFκB signaling is activated within the obese endometrium and AGEs promote p65 NFκB activation within endometrial epithelial cells p65 NFκB immunostaining was detected within the lean endometrium (Fig. 3A , n = 10 examined), mainly localized within scattered stromal cells and to a lesser extent within the glandular epithelium. More intense NFκB immunostaining was observed within the obese endometrium (Fig. 3B , n = 10). Quantification of immunohistochemical data demonstrated a significant increase in the intensity/extent of staining in the obese versus lean endometrium ( Fig. 3C , P < 0.05).
To investigate whether AGEs promote NFκB activation within the obese endometrium, endometrial epithelial (ECC-1) cells were treated with 'lean' (2000 nmol/mol lysine) or 'obese' (8000 nmol/mol lysine) levels of AGE-HSA in the presence of estrogen (Fig. 3D , E, H and I) or combined estrogen/progesterone (Fig. 3F , G, J and K) mimicking the proliferative and secretory phases of the menstrual cycle respectively. 'Obese' levels of AGEs had no significant impact on cytoplasmic IκB (inhibitor of NFκB) under estrogen alone ( Fig. 3D and E) or combined estrogen/progesterone ( Fig. 3F and G) . However, 'obese' levels of AGEs mediated a non-significant increase in nuclear p65 NFκB accumulation in the presence of estrogen (Fig. 3H and I ) and estrogen/progesterone ( Fig. 3J and K) versus 'lean' AGEs ( Fig. 3I and K).
Obese levels of AGEs detrimentally impact endometrial epithelial (ECC-1) cell function
'Obese' AGEs in presence of estrogen significantly inhibited cell adhesion to fibronectin at 2, 3, 4 and 5 h ( (Fig. 3B) versus lean (Fig. 3A) endometrium. Quantification of immunohistochemical data demonstrated a significant elevation in NFkB staining within the obese (red, Fig. 3C , n = 10) versus lean endometrium (blue, Fig. 3C , n = 10). Treatment of ECC-1 cells with levels of AGEs equimolar with those within lean (2000 nmol/mol lysine, blue) versus obese (8000 nmol/mol lysine, red) uterine fluid had no significant impact on cytoplasmic IκB levels under the influence of estrogen ( Fig. 3D and E) or combined estrogen/progesterone ( Fig. 3F and G) , but elevated (non-significant) nuclear accumulation of NFκB in the presence of estrogen alone ( Fig. 3H and I) or combined estrogen/progesterone ( Fig. 3J and K) . Data presented as mean ± SD. Combined data from n = 3 experiments. Scale bars in Fig. 3A and B = 50 μM. Isotype matched IgG negative control sections of same tissues inset into each panel. Representative western immunoblot images presented.
Endometrial stromal cell decidualization is impacted and ER stress responses activated by obese AGE levels Cellular morphology at 12 days suggested a detrimental impact of 'obese' AGEs on decidualization of primary endometrial stromal cells (n = 6); cells treated with 'lean' AGEs exhibited a typical rounded, 'cobblestone' morphology indicative of decidualization (Fig. 5A) , whereas cells treated with 'obese' AGEs maintained fibroblastic morphology (Fig. 5B) . However, prolactin assessment revealed an increase in prolactin release by primary stromal cells treated with 'obese' levels of AGEs (Fig. 5C ) versus 'lean' AGE treatment ( Fig. 5C , P = 0.02). This unexpected finding was further examined. The endoplasmic reticulum (ER) unfolded protein response (UPR) is activated in response to cell stress in an attempt to normalize cell function, this can lead to increased protein production. P-PERK, a marker of ER stress, was increased in cells treated with 'obese' AGEs ( Fig. 5D and E) versus cells treated with 'lean' AGEs ( Fig. 5D and E, P = 0.03) on Day 12 of decidualization.
Obese levels of AGEs inhibit 'embryo' adhesion
Treatment of endometrial epithelial (ECC-1) cells with estrogen/progesterone facilitated adhesion of 35% of trophectodermal spheroids at 6 h after spheroid placement on the ECC-1 monolayer (Fig. 6A) similar to the predicted implantation rate in natural conception cycles. Similarly, treatment of ECC-1 cells with 'lean' levels of AGEs under the same hormonal conditions, mediated a comparable level of trophectodermal spheroid adhesion (32%, Fig. 6A ). However, treatment with 'obese' levels of AGEs significantly inhibited spheroid adhesion, with just 6% adhesion of trophectodermal spheroids to ECC-1 cells pretreated with hormones/obese levels of AGEs (Fig. 6A , P = 0.001).
Trophoblast invasion, but not migration, is inhibited by obese AGEs
Treatment of HTR8/SV-neo cells with 'obese' levels of AGEs (Fig. 6B) had little effect on real-time trophoblast migration versus treatment with 'lean' AGE levels (Fig. 6B) . However, 'obese' levels of AGEs significantly inhibited real-time trophoblast invasion (Fig. 6C ) from 20 to 36 h versus treatment with 'lean' levels of AGEs (Fig. 6C , *P < 0.05).
Discussion
This study provides strong scientific evidence to support clinical reports of an adverse impact of obesity on endometrial function. In particular, it demonstrates detrimental actions of a specific family of protein modifications, the AGEs, significantly elevated within the obese endometrial environment, on cell functions important for receptivity, implantation and placentation. Globally, obesity is now more common than being underweight, and a large proportion of daily caloric intake is derived from sugar, leading to obesity. The implications of the negative effects of AGEs, sugar related molecules, on fertility, fecundity and birth outcomes, therefore, become highly significant. Importantly, it provides new avenues for the investigation and remedy of infertility and complications of early pregnancy.
We demonstrate for the first time, elevated levels of the highly inflammatory AGEs (Kellow and Coughlan, 2015) within the uterine cavity of obese women, congruent with elevation of the AGE receptor, RAGE, within endometrial glandular epithelial cells, providing a mechanism for AGE-RAGE-mediated inflammatory signaling. We further demonstrate that levels of AGEs equimolar with those within the uterine cavity of obese patients alter cellular function within the female reproductive tract. Application of 'obese' AGEs (in vitro prepared AGE-HSA equimolar with the obese uterine environment measured in uterine fluid), to endometrial cells in vitro promoted nuclear accumulation of NFκB (albeit statistically non-significant); critical for binding to the response elements of NFκB responsive genes. Factors within the uterine cavity have a strong potential to alter embryonic development at least in part through epigenetic changes. A recent multicenter randomized controlled trial (RCT) demonstrated that a difference in birth-weight outcomes in IVF can be mediated by differences in embryo culture media composition (Kleijkers et al., 2016) , mainly simple salts and amino acids. Hence, the profound differences in fetal outcomes observed in obese women are likely mediated, in part, via highly elevated endometrial AGE levels and an inflammatory local environment.
We demonstrate that obese AGE levels alter endometrial epithelial cell function. Under the 'proliferative phase' influence of estrogen these data have implications for the regeneration of the endometrium during the proliferative phase. Under the influence of 'secretory phase' estrogen/progesterone, these data have implications for the adhesiveness of the endometrial epithelial cells for the implanting blastocyst. Fibronectin, the extracellular matrix in the current study, is expressed on the surface of the human pre-implantation blastocyst (Shimomura et al., 2006) . Therefore, the down-regulated endometrial epithelial cell adhesion competence for fibronectin mediated by AGEs suggests the blastocyst adhesion may be compromised in obese women. Clinically, delayed adhesion, and therefore implantation potential, may be associated with an increased incidence of early pregnancy loss (Wilcox et al., 1999) . Obese women experience a higher incidence of early pregnancy loss than lean women (Boots et al., 2014; Ledger, 2016) . This is supported by our unique 'embryo' adhesion assay in which obese AGEs significantly inhibited 'embryo' adhesion to a hormonally primed endometrial epithelial layer.
Appropriate stromal decidualization is critical in the selection of good quality embryos (Salker et al., 2010; Weimar et al., 2012) . Here, obese AGEs detrimentally impacted decidualization, with cellular morphology suggestive of a complete lack of estrogen/progesteronemediated decidual transformation. It was therefore surprising to find significant elevation in secretion of the decidual marker prolactin by these morphologically non-decidualized cells. Insults by an external stressor can cause ER stress which leads to activation of the UPR. Herein, via phosphorylation of PERK, one of the intracellular factors implementing the UPR (Teske et al., 2011) , we demonstrate that obese AGEs mediate ER stress. Activation of the UPR usually acts to normalize the function of the ER in an attempt to stabilize cellular function but leads to cell death if function cannot be stabilized. Closer examination of the morphological presentation of stromal cells treated with obese AGEs indicated the presence of a number of dead/dying cells; however, these were present in association with elevated prolactin release. Upon activation of the UPR it has been observed, for example, in immune cells, that protein production is temporarily increased and the terminal UPR response resulting in apoptosis can be (Fig. 5A ) and prolactin secretion (Fig. 5C ). In the presence of the same hormonal milieu and obese levels of AGEs (8000 nmol/mol lysine, red), endometrial stromal cells maintained a non-decidualized fibroblastic morphology with some evidence of cell death (rounded, floating cells, Fig. 5B ), in association with a significant elevation in prolactin secretion (Fig. 5C ).
Western immunoblot analysis demonstrated a significant elevation in the ER stress marker phospho-PERK in stromal cells treated with obese (8000 nmol/mol lysine, red) versus lean (2000 nmol/mol lysine, blue) levels of AGEs ( Fig. 5D and E, P = 0.03). Data presented as mean ± SEM. Combined data from n = 6 stromal cell preparations from individual women. Representative western immunoblot images presented.
avoided for a short period (Grootjans et al., 2016) . However, if cell function cannot be stabilized, apoptosis ensues. These data may suggest that activation of ER stress and the UPR initially resulted in increased protein (prolactin) but cellular function could not be normalized eventually resulting in cell death. The sum of these data indicate primary stromal cell function is profoundly affected by obese AGEs, potentially reducing their decidualization within the endometrium of obese women and thereby further contributing to reduced fertility and fecundity. AGEs induce secretion of chemokines and apoptosis in primary first trimester trophoblast cells (Konishi et al., 2004) and trigger reactive oxygen species (ROS)-induced sFlt-1 production in extravillous trophoblast (Huang et al., 2013) in a suggested link with development of pre-eclampsia. Obesity is one of the major modifiable risk factors for development of pre-eclampsia and AGE-RAGE signaling is proposed to be elevated in pre-eclamptic placentas (Alexander et al., 2016) . How data from term placentas relate to the initiation of the disease in the first trimester is unknown. Here, obese levels of AGEs significantly inhibited trophoblast invasion. Invasion of extravillous trophoblasts through the maternal endometrium during the first trimester is essential for appropriate placental formation and spiral artery remodeling. Placental invasion is compromised/inadequate in pre-eclamptic placentas, providing a hallmark of severe early onset pre-eclampsia (Saito and Nakashima, 2014) . Our data therefore support a role for elevated AGEs in the pathophysiology of pre-eclampsia and may help explain why obese women are at a higher risk of pre-eclamptic pregnancies.
Our findings represent an important step in unraveling the reproductive consequences of obesity and the specific impact of obesity associated AGEs on fertility and fecundity. Larger clinical studies will logically follow, to confirm the in vivo relevance of these findings. Assessment of uterine AGE levels may be utilized as a predictor of potential implantation success in natural conception and/or IVF cycles in general populations not exclusively those with obesity. High AGE levels may preclude women from undergoing fertility assistance until levels are managed in order to enhance success rates. Further studies should include dietary intervention strategies; indeed, dietary and exercise intervention in obese women significantly increases fertility (Moran et al., 2011) . Additionally, targeting AGEs for breakdown with pharmacological agents such as the AGE breaker alagebrium, or targeting AGE-RAGE activation, may be an appropriate therapeutic strategy for older women with elevated AGE levels who may not have time for weight loss before reproductive senescence. These data therefore provide scientific support for published clinical findings, and expand current knowledge of the influence of obesity on fertility beyond A B C Figure 6 Obese AGEs reduce 'embryo' implantation competence. Pre-treatment of ECC-1 cells with obese levels of AGEs (8000 nmol/mol lysine, red) in the presence of estrogen/progesterone (E/P), significantly inhibited adhesion of trophectodermal spheroids to the epithelial monolayer versus treatment with E/P alone (grey) or in the presence of lean levels of AGEs (2000 nmol/mol lysine, blue, P = 0.001). Data presented as mean ± SEM. Combined data from n = 5 experiments (Fig. 6A) . Treatment of HTR8/SV-neo trophoblast cells with obese levels of AGEs (8000 nmol/mol lysine, red) had no effect on trophoblast migration (Fig. 6B ), but significantly inhibited trophoblast invasion (Fig. 6C ) from 20 to 36 h versus treatment with lean levels of AGEs (2000 nmol/mol lysine, blue, *P < 0.05). Data presented as mean ± SEM. Combined data from n = 5 experiments.
actions on gametes, to the endometrium, placental development and pregnancy outcomes.
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